Case series:Apatinib combined with SOX

2 trials

Sponsors

Lanzhou University Second Hospital, Gansu Province Cancer Hospital

Conditions

Advanced gastric cancer or adenocarcinoma of the esophageal junction of the stomachnot operable, recurrent or metastatic advanced gastric or gastric esophageal junction adenocarcinoma

Phase 4

A single-arm exploratory Clinical study of Apatinib combination with SOX as First line treatment in patients with advanced gastric cancer

Active, not recruitingChiCTR1800016932

Lanzhou University Second HospitalAdvanced gastric cancer or adenocarcinoma of the esophageal junction of the stomach

Start: 2018-06-30Updated: 2018-07-09

A single-arm, prospective Clinical Study of apatinib combined with SOX protocol for first-line treatment of advanced gastric cancer

Active, not recruitingChiCTR1800017837

Gansu Province Cancer Hospitalnot operable, recurrent or metastatic advanced gastric or gastric esophageal junction adenocarcinoma

Start: 2018-08-30Updated: 2018-08-20